2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide
C20H23F4N5O3S — CID 139556939
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide
2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide (PubChem CID 139556939) has the molecular formula C20H23F4N5O3S and a molecular weight of 489.50 g/mol. Its IUPAC name is 2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 139556939 |
| Molecular Formula | C20H23F4N5O3S |
| Molecular Weight | 489.50 g/mol |
| Exact Mass | 489.15 |
| IUPAC Name | 2-[4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-5-(trifluoromethyl)pyrimidine-4-carboxamide |
| SMILES | CC(C)C1CN(c2ccc(F)c(S(C)(=O)=O)c2)CCN1c1ncc(C(F)(F)F)c(C(N)=O)n1 |
| InChI | InChI=1S/C20H23F4N5O3S/c1-11(2)15-10-28(12-4-5-14(21)16(8-12)33(3,31)32)6-7-29(15)19-26-9-13(20(22,23)24)17(27-19)18(25)30/h4-5,8-9,11,15H,6-7,10H2,1-3H3,(H2,25,30) |
| InChIKey | MOLPHGVUKWQWMX-UHFFFAOYSA-N |
| XLogP | 2.49 |
| TPSA | 109.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.50 |
| LogP ≤ 5 | 2.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139556939 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.